Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)

Context Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for qualit...

Full description

Bibliographic Details
Main Authors: Shuaishuai Chen, Xiaojuan Yang, Ziying Wei, Yanru Zhang, Ying Huang, Zhuo Shi, Ziteng Zhang, Jiabo Wang, Haizhu Zhang, Jianli Ma, Xiaohe Xiao, Ming Niu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Pharmaceutical Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/13880209.2021.1917627
id doaj-b591df432d1e4bf0ac77902b07c6dfd1
record_format Article
spelling doaj-b591df432d1e4bf0ac77902b07c6dfd12021-05-06T15:44:48ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162021-01-0159153754510.1080/13880209.2021.19176271917627Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)Shuaishuai Chen0Xiaojuan Yang1Ziying Wei2Yanru Zhang3Ying Huang4Zhuo Shi5Ziteng Zhang6Jiabo Wang7Haizhu Zhang8Jianli Ma9Xiaohe Xiao10Ming Niu11School of Pharmacy, Chengdu University of Traditional Chinese MedicineChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalCollege of Pharmacy and Chemistry, Dali UniversityDepartment of Pharmacy, The Fourth Medical Center of Chinese, PLA General HospitalChina Military Institute of Chinese Medicine, The Fifth Medical Center of Chinese, PLA General HospitalDepartment of Hematology, The Fifth Medical Center of Chinese, PLA General HospitalContext Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for quality control. Materials and methods Network pharmacology was used to screen potential targets in LHQW with respect to its anti-inflammatory effects. An in vitro cell model was used to validate the prediction. An anti-inflammatory bioassay was established for the quality evaluation of LHQW in 40 batches of marketed products and three batches of destructed samples. Results The tumor necrosis factor/interleukin-6 (TNF/IL-6) pathway via macrophage was selected as the potential target of LHQW. The IC50 value of LHQW on RAW 264.7 was 799.8 μg/mL. LHQW had significant inhibitory effects on the expression of IL-6 in a dose-dependent manner (p < 0.05). The anti-inflammatory biopotency of LHQW was calculated based on the inhibitory bioactivity on IL-6. The biopotency of 40 marketed samples ranged from 404 U/μg to 2171 U/μg, with a coefficient of variation (CV) of 37.91%. By contrast, the contents of forsythin indicated lower CV (28.05%) than the value of biopotency. Moreover, the biopotencies of destructed samples declined approximate 50%, while the contents of forsythin did not change. This newly established bioassay revealed a better ability to discriminate the quality variations of LHQW as compared to the routine chemical determination. Conclusions A well-established bioassay may have promising ability to reveal the variance in quality of TCM.http://dx.doi.org/10.1080/13880209.2021.1917627biopotencymacrophagenetwork pharmacologyquality variationinterleukin-6
collection DOAJ
language English
format Article
sources DOAJ
author Shuaishuai Chen
Xiaojuan Yang
Ziying Wei
Yanru Zhang
Ying Huang
Zhuo Shi
Ziteng Zhang
Jiabo Wang
Haizhu Zhang
Jianli Ma
Xiaohe Xiao
Ming Niu
spellingShingle Shuaishuai Chen
Xiaojuan Yang
Ziying Wei
Yanru Zhang
Ying Huang
Zhuo Shi
Ziteng Zhang
Jiabo Wang
Haizhu Zhang
Jianli Ma
Xiaohe Xiao
Ming Niu
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
Pharmaceutical Biology
biopotency
macrophage
network pharmacology
quality variation
interleukin-6
author_facet Shuaishuai Chen
Xiaojuan Yang
Ziying Wei
Yanru Zhang
Ying Huang
Zhuo Shi
Ziteng Zhang
Jiabo Wang
Haizhu Zhang
Jianli Ma
Xiaohe Xiao
Ming Niu
author_sort Shuaishuai Chen
title Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
title_short Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
title_full Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
title_fullStr Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
title_full_unstemmed Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
title_sort establishment of an anti-inflammation-based bioassay for the quality control of the 13-component tcm formula (lianhua qingwen)
publisher Taylor & Francis Group
series Pharmaceutical Biology
issn 1388-0209
1744-5116
publishDate 2021-01-01
description Context Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. Objective Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for quality control. Materials and methods Network pharmacology was used to screen potential targets in LHQW with respect to its anti-inflammatory effects. An in vitro cell model was used to validate the prediction. An anti-inflammatory bioassay was established for the quality evaluation of LHQW in 40 batches of marketed products and three batches of destructed samples. Results The tumor necrosis factor/interleukin-6 (TNF/IL-6) pathway via macrophage was selected as the potential target of LHQW. The IC50 value of LHQW on RAW 264.7 was 799.8 μg/mL. LHQW had significant inhibitory effects on the expression of IL-6 in a dose-dependent manner (p < 0.05). The anti-inflammatory biopotency of LHQW was calculated based on the inhibitory bioactivity on IL-6. The biopotency of 40 marketed samples ranged from 404 U/μg to 2171 U/μg, with a coefficient of variation (CV) of 37.91%. By contrast, the contents of forsythin indicated lower CV (28.05%) than the value of biopotency. Moreover, the biopotencies of destructed samples declined approximate 50%, while the contents of forsythin did not change. This newly established bioassay revealed a better ability to discriminate the quality variations of LHQW as compared to the routine chemical determination. Conclusions A well-established bioassay may have promising ability to reveal the variance in quality of TCM.
topic biopotency
macrophage
network pharmacology
quality variation
interleukin-6
url http://dx.doi.org/10.1080/13880209.2021.1917627
work_keys_str_mv AT shuaishuaichen establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT xiaojuanyang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT ziyingwei establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT yanruzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT yinghuang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT zhuoshi establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT zitengzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT jiabowang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT haizhuzhang establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT jianlima establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT xiaohexiao establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
AT mingniu establishmentofanantiinflammationbasedbioassayforthequalitycontrolofthe13componenttcmformulalianhuaqingwen
_version_ 1721456527570632704